Table 1 Characteristics of cholangiocarcinoma patients for discovery cohort.

From: Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression

Characteristic

N (%)

Age

 

Range min-max (average)

44–79 (62.5)

Gender

 

Male

13(65)

Female

7(35)

Subtype primary CCA

 

Intrahepatic Bile Ducts

6 (30)

Extrahepatic Bile Ducts

14 (70)

Histology

 

Tubular

15 (75)

Papillary

5 (25)

TNM stage

 

Early stage (I-II)

6 (30)

Late stage (III-IV)

14 (70)

HDRA cisplatin response

 

Response

8 (40)

Non-response

12 (60)

Total

20

Back to article page